Research NewsImmunology

New Lead to Safer Marrow Transplants

See allHide authors and affiliations

Science  13 Jun 1997:
Vol. 276, Issue 5319, pp. 1646
DOI: 10.1126/science.276.5319.1646

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

In at least half of bone-marrow transplant patients, the donor immune cells turn against the recipient's own tissues, triggering a deadly ailment called graft-versus-host disease. Now doctors led by hematologist Claudio Bordignon at the San Raffaele Scientific Institute in Milan, Italy, may have found a solution. On page 1719 of this issue, they report the first successful human test of a gene therapy designed to halt the attack of the donated cells on the recipients' tissues.